TLR10 encodes Toll-Like Receptor 10, a member of the TLR family that is unique among human TLRs for several reasons. It is the only TLR gene located in a TLR gene cluster (with TLR1 and TLR6) on chromosome 4p14, and it represents the least characterized human TLR due to its lack of functional expression in commonly used model systems. Despite these challenges, emerging research indicates that TLR10 plays important roles in innate immunity, inflammation modulation, and potentially in neuroinflammatory conditions affecting the central nervous system[1].
TLR10 is a type I transmembrane pattern recognition receptor belonging to the TLR1/2/6/10 subfamily. Unlike other TLRs, TLR10 has proven difficult to study because it does not signal efficiently in standard cell lines, and for many years it was considered a pseudogene in mice. However, human TLR10 is a functional receptor with distinct characteristics:
The unique genomic organization of TLR10, TLR1, and TLR6 in a tandem array suggests they evolved through gene duplication and may have overlapping or compensatory functions.
TLR10 contains the characteristic TLR domain organization:
Leucine-Rich Repeat (LRR) domain: Extracellular region containing 20-25 LRRs
Transmembrane domain: Single pass α-helical segment
TIR (Toll/IL-1 Receptor) domain: Cytoplasmic signaling domain
TLR10 signaling is complex and differs from other TLRs:
MyD88-Dependent Pathway (primary):
Negative Regulation:
B Cell-Specific Signaling:
| Cell Type | Expression Level | Functional Role |
|---|---|---|
| Microglia | Low-Moderate | Neuroinflammation modulation |
| Astrocytes | Low | Stress response |
| Neurons | Very Low | Limited expression |
| Oligodendrocytes | Very Low | Not well characterized |
| Perivascular macrophages | Moderate | Immune surveillance |
TLR10 expression in the brain is lower than other TLRs (TLR2, TLR4) but is detectable in:
Association: TLR10 genetic variants have been linked to AD risk in some populations[2]
Mechanisms:
Evidence:
Association: TLR10 implicated in PD pathogenesis[3]
Mechanisms:
Evidence:
Association: Altered TLR10 in various autoimmune conditions
Specific Associations:
Mechanism: Dysregulated TLR10 may contribute to autoimmunity through altered immune cell activation thresholds.
Association: TLR10 plays roles in cardiovascular disease
Mechanisms:
Association: TLR10 variants influence TB susceptibility
Evidence:
| SNP | Location | Function | Disease Association |
|---|---|---|---|
| rs5743809 | Promoter | Altered expression | TB susceptibility |
| rs5743810 | Coding (V321I) | Missense | Modified signaling |
| rs10856839 | Intron | Unknown | AD risk |
| rs4696480 | Promoter | Transcription factor binding | Autoimmune disease |
| Strategy | Approach | Development Status |
|---|---|---|
| Agonists | Synthetic TLR10 ligands | Preclinical |
| Antagonists | Blocking antibodies | Research |
| Gene therapy | Expression modulation | Early stage |
| SNPs | Personalized medicine | Investigation |
Known and potential TLR10 ligands include:
TLR10 is most closely related to TLR1 and TLR6:
| Feature | TLR10 | TLR1 | TLR6 |
|---|---|---|---|
| Chromosome | 4p14 | 4p14 | 4p14 |
| Heterodimers | TLR2 | TLR2 | TLR2 |
| Signaling | MyD88 | MyD88 | MyD88 |
| Ligand specificity | Limited | Triacylated lipoproteins | Diacylated lipoproteins |
| Brain expression | Low | Moderate | Moderate |
The study of Tlr10 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta. 2001;1518(1-2):157-161.
[2] Zhang Y, et al. Toll-like receptor polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2018;63(2):545-559.
[3] Kim C, et al. Toll-like receptors in neurodegenerative diseases. Exp Neurobiol. 2019;28(3):295-306.
[4] Hasan U, et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene expression through MyD88. J Immunol. 2005;174(5):2942-2950.
[5] Lee SM, et al. TLR10 modulates innate immune responses to Mycobacterium tuberculosis. Infect Immun. 2013;81(5):1678-1687.